首页> 外文OA文献 >ND4 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS: MODEL UTILIZING FIVE YEAR BENEFIT DATA

【2h】

ND4 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS: MODEL UTILIZING FIVE YEAR BENEFIT DATA

机译：干扰素BETA-1B在多发性硬化症临床隔离综合征患者中的成本效用：利用五年受益数据的模型

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Caloyeras JP; Harrow B; Wang C; Beckmann K; Knappertz V; Pohl C; Miller JD; Russell MW; Sandbrink R; Gondek K;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. [J] . Kappos L, Freedman MS, Polman CH, The Lancet . 2007,第9585期

机译：首次临床事件提示多发性硬化后，早期干扰素与延迟干扰素β-1b治疗对残疾的影响：BENEFIT研究的3年随访分析。
2. Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis [J] . CaloyerasJ.P., ZhangB., WangC., Clinical therapeutics . 2012,第5期

机译：干扰素β-1b治疗首例提示多发性硬化的临床事件的成本效果分析
3. Clinical Outcomes in Patients with Clinically Isolated Syndrome (CIS) Treated with Interferon beta-1b (11-Year Follow-Up of BENEFIT) [J] . Kappos Ludwig, Edan Gilles, Freedman Mark S., Annals of neurology . 2014,第Suppla18期

机译：干扰素beta-1b治疗临床孤立综合征（CIS）患者的临床结果（BENEFIT的11年随访）
4. Prognostic Value of Brain Tissue Pathological Changes in Patients with Clinically Isolated Syndromes (CIS) Suggestive of Multiple Sclerosis Using Magnetization Transfer Ratio (MTR) [C] . Fooladi, M., Alam, Engineering in Medicine and Biology Society, 2007 Annual International Conference of the IEEE . 2007

机译：磁化转移率（MTR）提示多发性硬化的临床孤立综合征（CIS）患者脑组织病理学改变的预后价值
5. Statistical Models for Count Data from Multiple Sclerosis Clinical Trials and their Applications. [D] . Rettiganti, Mallikarjuna Rao. 2010

机译：多发性硬化症临床试验计数数据的统计模型及其应用。
6. Correction: Observational study assessing demographic economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA) [O] . Georgios Hadjigeorgiou, Efthimios Dardiotis, Georgios Tsivgoulis, -1

机译：更正：一项观察性研究评估与接受β-1b干扰素（EXTAVIA）治疗的多发性硬化症患者获得和利用医疗保健服务相关的人口统计经济和临床因素
7. PND26 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS IN SPAIN [O] . Arbizu T, Piñol C, Casado V 2009

机译：PND26干扰素BETA-1B在西班牙多发性硬化症临床隔离综合征患者中的治疗效用

ND4 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS: MODEL UTILIZING FIVE YEAR BENEFIT DATA

著录项

引文网络

相似文献

相关主题

期刊订阅